National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States

Journal of Allergy and Clinical Immunology: In Practice

Volumn 6, Issue 2, 2018, Pages 536-544.e1

  Sullivan, Patrick W ^a   Ghushchyan, Vahram ^b,c   Navaratnam, Prakash ^d   Friedman, Howard S ^d   Kavati, Abhishek ^e   Ortiz, Benjamin ^e   Lanier, Bobby ^f  

^a REGIS UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c AMERICAN UNIVERSITY OF ARMENIA   (Armenia)

^d Data Solutions LLC   (United States)

^e NOVARTIS PHARMA AG   (Switzerland)

^f UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Asthma; Asthma control; Children; Expenditures; Health resource utilization

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIASTHMATIC AGENT;

ARTICLE; ASTHMA; CHILD; CLINICAL OUTCOME; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT DURATION; UNITED STATES; ADOLESCENT; QUESTIONNAIRE; TREATMENT OUTCOME;

ADOLESCENT; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES;

EID: 85028356494     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2017.06.039     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention, Most Recent Asthma Data; 2016. Available from: https://www.cdc.gov/asthma/most_recent_data.htm. (Accessed 22 December 2016)
2. American Lung Association, Asthma & Children Fact Sheet; 2017. Available from: http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/asthma/learn-about-asthma/asthma-children-facts-sheet.html. (Accessed 4 March 2017)
3. Wang, L.Y., Zhong, Y., Wheeler, L., Direct and indirect costs of asthma in school-age children. Prev Chronic Dis, 2, 2005, A11.
4. Barnett, S.B., Nurmagambetov, T.A., Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol 127 (2011), 145–152.
5. National Heart Lung and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. Full report 2007. 2007, National Institutes of Health U.S. Department of Health and Human Services National Heart, Lung and Blood Institute, Bethesda, Md.
6. Halbert, R.J., Tinkelman, D.G., Globe, D.R., Lin, S.L., Measuring asthma control is the first step to patient management: a literature review. J Asthma 46 (2009), 659–664.
7. Sullivan, P.W., Slejko, J.F., Ghushchyan, V.H., Sucher, B., Globe, D.R., Lin, S.L., et al. The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma 51 (2014), 769–778.
8. Schatz, M., Zeiger, R.S., Vollmer, W.M., Mosen, D., Apter, A.J., Stibolt, T.B., et al. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 117 (2006), 995–1000.
9. Schatz, M., Zeiger, R.S., Vollmer, W.M., Mosen, D., Mendoza, G., Apter, A.J., et al. The controller-to-total asthma medication ratio is associated with patient-centered as well as utilization outcomes. Chest 130 (2006), 43–50.
10. Schatz, M., Zeiger, R.S., Yang, S.J., Chen, W., Crawford, W.W., Sajjan, S.G., et al. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database. Am J Manag Care 16 (2010), 327–333.
11. Slejko, J.F., Ghushchyan, V.H., Sucher, B., Globe, D.R., Lin, S.L., Globe, G., et al. Asthma control in the United States, 2008-2010: indicators of poor asthma control. J Allergy Clin Immunol 133 (2014), 1579–1587.
12. Anderson, W.C. III, Szefler, S.J., New and future strategies to improve asthma control in children. J Allergy Clin Immunol 136 (2015), 848–859.
13. Szefler, S.J., Chmiel, J.F., Fitzpatrick, A.M., Giacoia, G., Green, T.P., Jackson, D.J., et al. Asthma across the ages: knowledge gaps in childhood asthma. J Allergy Clin Immunol 133 (2014), 3–13 quiz 14.
14. Lodge, C.J., Lowe, A.J., Allen, K.J., Zaloumis, S., Gurrin, L.C., Matheson, M.C., et al. Childhood wheeze phenotypes show less than expected growth in FEV1 across adolescence. Am J Respir Crit Care Med 189 (2014), 1351–1358.
15. Strunk, R.C., Weiss, S.T., Yates, K.P., Tonascia, J., Zeiger, R.S., Szefler, S.J., et al. Mild to moderate asthma affects lung growth in children and adolescents. J Allergy Clin Immunol 118 (2006), 1040–1047.
16. Tai, A., Tran, H., Roberts, M., Clarke, N., Gibson, A.M., Vidmar, S., et al. Outcomes of childhood asthma to the age of 50 years. J Allergy Clin Immunol 133 (2014), 1572–1578.e3.
17. Centers for Disease Control and Prevention, Uncontrolled Asthma among Persons with Current Asthma; 2014. Available from: https://www.cdc.gov/asthma/asthma_stats/uncontrolled_asthma.htm. (Accessed 23 January 2017)
18. Patel, M.R., Brown, R.W., Clark, N.M., Perceived parent financial burden and asthma outcomes in low-income, urban children. J Urban Health 90 (2013), 329–342.
19. Sullivan, P.W., Ghushchyan, V.H., Slejko, J.F., Belozeroff, V., Globe, D.R., Lin, S.-L., The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol, 127, 2011 363-369.e1-3.